Lexicon Pharmaceuticals Ratios (2010-2025) | LXRX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Profitability
Gross Margin (Quarter)	100.00%		100.00%	100.00%			100.00%	100.00%		97.25%	95.27%	90.86%	97.26%	89.92%	95.94%	98.69%	97.62%	99.89%	99.93%	96.34%
EBT Margin (Quarter)	-77,800.00%		-100,578.26%	9,022.89%			-61,433.33%	-112,075.00%		-15,876.29%	-36,168.92%	-6,101.44%	-4,011.77%	-3,360.90%	-3,639.60%	-123.28%	-2,034.79%	12.94%	-85.93%	-269.07%
EBIT Margin (Quarter)	-77,181.48%		-99,834.78%	8,919.01%			-59,217.95%	-108,135.71%		-15,202.75%	-33,534.46%	-6,101.44%	-4,011.77%	-3,360.90%	-3,639.60%	-123.28%	-2,034.79%	12.94%	-85.93%	-269.07%
EBITDA Margin (Quarter)	-77,581.48%		-100,530.43%	9,019.72%			-60,841.03%	-108,682.14%		-15,409.28%	-34,147.30%	-6,476.76%	-4,290.09%	-3,252.70%	-3,672.51%	-128.03%	-2,011.81%	11.13%	-89.73%	-282.71%
Operating Margin (Quarter)	-77,181.48%		-99,834.78%	8,919.01%			-59,217.95%	-108,135.71%		-15,202.75%	-33,534.46%	-6,101.44%	-4,011.77%	-3,360.90%	-3,639.60%	-123.28%	-2,034.79%	12.94%	-85.93%	-269.07%
Net Margin (Quarter)	-77,800.00%		-100,578.26%	9,022.89%			-61,433.33%	-112,075.00%		-15,876.29%	-36,168.92%	-6,101.44%	-4,011.77%	-3,360.90%	-3,639.60%	-123.28%	-2,034.79%	12.94%	-85.93%	-269.07%
FCF Margin (Quarter)	-93,322.22%		-75,491.30%	8,046.13%			-49,853.85%	-81,482.14%		-13,146.39%	-28,177.03%	-6,598.96%	-4,878.76%	-2,962.36%	-3,081.49%	-82.72%	-3,468.94%	58.87%	-168.05%	-313.73%
Efficiency
Inventory Average (Quarter)											0.25M	0.36M	0.45M	0.55M	0.61M	0.43M	0.22M	0.18M	0.16M	0.22M
Assets Average (Quarter)	198.52M	182.47M	172.00M	154.62M	136.54M	124.25M	152.00M	192.99M	178.51M	239.72M	296.60M	252.95M	323.32M	395.29M	347.24M	309.77M	298.05M	261.63M	215.75M	195.46M
Equity Average (Quarter)	154.46M	144.89M	136.92M	125.10M	103.15M	81.76M	107.42M	130.57M	102.58M	137.20M	162.94M	116.31M	190.99M	264.42M	209.25M	162.23M	134.49M	126.24M	124.80M	113.85M
Invested Capital (Quarter)	164.21M	148.91M	148.30M	113.59M	116.20M	94.43M	167.82M	165.72M	136.85M	285.16M	238.81M	93.11M	288.87M	239.98M	178.51M	145.95M	165.09M	129.44M	120.16M	112.13M
Asset Utilization Ratio (Quarter)	0.03	0.03	0.00	0.00		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.02	0.10	0.10	0.22	0.33	0.25
Leverage & Solvency
Interest Coverage Ratio (Quarter)	-124.78	-106.27	-134.28	-85.86	-212.55	-34.15	-26.73	-27.45	-17.10	-22.57	-12.73
Debt to Equity (Quarter)	0.08	0.09	0.09		0.25	0.33	0.17	0.41	0.55	0.53	0.71	1.07	0.35	0.41	0.56	0.69	0.82	0.43	0.47	0.50
Debt Ratio (Quarter)	0.06	0.07	0.07		0.17	0.21	0.12	0.25	0.30	0.31	0.36	0.43	0.24	0.27	0.31	0.34	0.34	0.25	0.27	0.29
Equity Ratio (Quarter)	0.79	0.80	0.79	0.83	0.68	0.63	0.75	0.60	0.54	0.59	0.50	0.41	0.69	0.64	0.56	0.49	0.41	0.57	0.58	0.58
Times Interest Earned (Quarter)	-124.78	-106.27	-134.28	-85.86	-212.55	-34.15	-26.73	-27.45	-17.10	-22.57	-12.73
Valuation
Enterprise Value (Quarter)	-141.36M	-118.50M	-120.92M	-86.74M	-86.50M	-61.97M	-136.20M	-138.36M	-105.94M	-256.74M	-218.43M	-170.03M	-355.60M	-309.96M	-258.37M	-237.96M	-194.84M	-139.01M	-115.95M	-96.23M
Return Ratios
Return on Sales (Quarter)	-7.78%	0.06%	-10.06%	0.90%		3.71%	-6.14%	-11.21%	-16.87%	-1.59%	-3.62%	-0.61%	-0.40%	-0.34%	-0.36%	-0.01%	-0.20%	0.00%	-0.01%	-0.03%
Return on Capital Employed (Quarter)	-3.89%	27.01%	-50.25%	-65.73%	-76.19%	-89.10%	-71.74%	-59.33%	-68.63%	-60.28%	-58.75%	-77.57%	-62.00%	-53.63%	-67.84%	-74.52%	-94.72%	-52.19%	-34.46%	-28.01%
Return on Invested Capital (Quarter)
Return on Assets (Quarter)	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.02%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%

Research Tools

Lexicon Pharmaceuticals Ratios (2010-2025) | LXRX

Create an account

Sign In

Reset Password